{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:43:14Z","timestamp":1784191394077,"version":"3.55.0"},"reference-count":19,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>We report the occurrence of skin toxicities in pediatric oncology patients on concomitant treatment with voriconazole and methotrexate (MTX). Of 23 patients who received this combination, 11 patients suffered from cheilitis and\/or photosensitivity. In contrast, only in 1 of 9 patients who received voriconazole without MTX was photosensitivity observed. A mechanism of action was not able to be identified. We describe two cases with severe skin toxicities. Caution is warranted when using voriconazole and concomitant MTX.<\/jats:p>","DOI":"10.1128\/aac.00068-13","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T01:21:41Z","timestamp":1365556901000},"page":"2878-2881","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Severe Skin Toxicity in Pediatric Oncology Patients Treated with Voriconazole and Concomitant Methotrexate"],"prefix":"10.1128","volume":"57","author":[{"given":"Johan G. C.","family":"van Hasselt","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Pharmacy &amp; Pharmacology, Slotervaart Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K. A.","family":"van Eijkelenburg","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin D. R.","family":"Huitema","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Pharmacy &amp; Pharmacology, Slotervaart Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H. M.","family":"Schellens","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology &amp; Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette Y. N.","family":"Schouten-van Meeteren","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"548","article-title":"Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease","volume":"10","author":"Hani N","year":"2000","unstructured":"HaniN CasperC GrothW KriegT HunzelmannN. 2000. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease. Eur. J. Dermatol. 10:548\u2013550.","journal-title":"Eur. J. Dermatol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70079-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70259-3"},{"key":"e_1_3_2_5_2","volume-title":"Common terminology criteria for adverse events (CTCAE), version 4.0","author":"National Cancer Institute","year":"2009","unstructured":"National Cancer Institute. 2009. Common terminology criteria for adverse events (CTCAE), version 4.0. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199711000-00008"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200302000-00006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H671"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80126-1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00909.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2010.07563.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08880010590907320"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1999.00105.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425250903463878"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(83)80032-2"},{"key":"e_1_3_2_17_2","first-page":"379","article-title":"Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature","volume":"66","author":"Khan AJ","year":"2000","unstructured":"KhanAJ MarghoobAA PrestiaAE SpectorIJ. 2000. Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature. Cutis 66:379\u2013382.","journal-title":"Cutis"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21896"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2008.00372.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.47276\/lr.78.4.401"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00068-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00068-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:27:10Z","timestamp":1645482430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00068-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1128\/AAC.00068-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.00068-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"2013-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}